IP Library Granted Patent US 7,737,274
Granted Patent B2
US 7,737,274 · App. 11/207,751 · Granted Jun 15, 2010

Methods for producing phenylalanine derivatives having a quinazolinedione skeleton and intermediates for production thereof

Assignee: Ajinomoto Co., Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,737,274
App. No.
11/207,751
Granted
Jun 15, 2010
Kind
B2
Abstract

The present invention provides a method for producing a phenylalanine derivative(s) having a quinazolinedione ring of formula (5), including steps comprising of reacting an acylphenylalanine derivative(s) of formula (1) with a carbonyl group-introducing reagent(s) and a derivative(s) of anthranilic acid to form an asymmetric urea intermediate(s); making the asymmetric urea intermediate(s) into a quinazolinedione compound(s) of formula (4) in the presence of a base(s); and N-alkylating quinazolinedione ring amide of the obtained quinazolinedione compounds with N-alkylation agents. This production method is an industrially applicable method for producing phenylalanine derivatives having a quinazolinedione skeleton, which are compounds highly useful as drugs having α 4 integrin inhibiting activity. In the formulae (1) and (5), R1 represents a phenyl group having a substituent(s) and the like, R2 represents an alkyl group and the like, R3 represents a dialkylamino group and the like, and R4 represents an alkyl group and the like.

Claims (17)

1. A method for producing a phenylalanine derivative(s) having a quinazolinedione ring of the following formula (5), comprising steps of

reacting an acylphenylalanine derivative(s) of formula (1):

wherein R1 represents a phenyl group which may have a substituent(s) or a pyridyl group which may have a substituent(s), R2 represents an alkyl group which may have a substituent(s), and the derivative(s) is in a salt(s) with chemically acceptable acid(s) or free form(s),

with a carbonyl group-introducing reagent(s) and an anthranilic acid derivative(s) of formula (2):

wherein R3 represents a dialkylamino group; R4 represents a hydrogen atom, an alkyl group or a benzyl group which may have a substituent(s); and R5 represents an alkyl group or an alkylcarbonyl group, and the derivative(s) is in a salt(s) with chemically acceptable acid(s) or free form(s),

to form an asymmetric urea intermediate(s) of formula (3):

wherein R1 to R5 are defined above;

making the asymmetric urea intermediate(s) into a quinazolinedione compound(s) of formula (4) in the presence of a base(s):

wherein R1 to R4 are defined above; and

when R4 represents a hydrogen atom in the obtained quinazolinedione compound(s) of the formula (4), N-alkylating a quinazolinedione ring amide of the quinazolinedione compound(s) with an N-alkylation agent(s) to form the phenylalanine derivative(s) having a quinazolinedione skeleton of formula (5):

wherein R1 to R3 are defined above, R4 represents an alkyl group or a benzyl group which may have a substituent(s).

2. The production method according to claim 1 , wherein the carbonyl group-introducing reagent is 1,1′-carbonyldiimidazole or chloroformate.

3. The production method according to claim 1 , wherein the base(s) represents a potassium carbonate or a sodium methoxide.

4. The production method according to claim 1 , wherein the N-alkylation agent is methyl p-toluenesulfonate.

5. The production method according to claim 1 , comprising steps of reacting a carbonyl group-introducing reagent selected from the group consisting of 1,1′-carbonyldiimidazole and chloroformate and the compound of the formula (2) wherein R3 represents a dimethylamino group, R4 represents a hydrogen atom and R5 represents a methyl group with the compound of the formula (1) wherein R1 represents a 2,6-dichlorophenyl group and R2 represents a methyl group to obtain methylester of 2-(3-{4-[2-(2,6-dichlorobenzoylamino)-2-methoxycarbonylethyl]phenyl}ureide)-5-dimethylaminobenzoic acid; converting it in the presence of potassium carbonate or sodium methoxide into methylester of N α -(2,6-dichlorobenzoyl)-4-(6-dimethylamino-2,4[1H,3H]-quinazolinedione-3-yl)-L-phenylalanine of the formula (4); and then N-alkylating it with methyl p-toluenesulfonate to obtain methylester of N α -(2,6-dichlorobenzoyl)-4-(1-methyl-6-dimethylamino-2,4[1H,3H]-quinazolinedione-3-yl)-L-phenylalanine.

6. The production method according to claim 1 comprising steps of reacting a carbonyl group-introducing reagent selected from the group consisting of 1,1′-carbonyldiimidazole and chloroformate and the compound of the formula (2) wherein R3 represents a dimethylamino group, R4 represents a methyl group and R5 represents a methyl group with the compound of the formula (1) wherein R1 represents a 2,6-dichlorophenyl group and R2 represents a methyl group to obtain the compound of the formula (3);

converting it in the presence of potassium carbonate or sodium methoxide into methylester of N α -(2,6-dichlorobenzoyl)-4-(1-methyl-6-dimethylamino-2,4[1H,3H]-quinazolinedione-3-yl)-L-phenylalanine.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2016
From: AJINOMOTO CO., INC.
To: EA PHARMA CO., LTD.
Reel/Frame 039094/0087 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2005
From: KATAOKA, NORIYASU; TATARA, AKINORI; YATAGAI, MASANOBU; YAMANAKA, JUNKO
To: AJINOMOTO CO., INC.
Reel/Frame 016913/0299 →
Continuity (2)
Continuation PCTJP200400198200 · Feb 20, 2004
Related Publication 20060009476A1 · Jan 12, 2006